Biogen Idec Inc. (NASDAQ: BIIB) announced today that its 2012 Annual
Shareholders Meeting will be webcast live on Friday, June 8, 2012 at
9:00 a.m. ET. To access the live webcast, please visit Biogen Idec’s
Investor Relations section (investor.biogenidec.com). An archived
version of the webcast will be available following the meeting.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers,
develops and delivers to patients worldwide innovative therapies for the
treatment of neurodegenerative diseases, hemophilia and autoimmune
disorders. Founded in 1978, Biogen Idec is the world’s oldest
independent biotechnology company. Patients worldwide benefit from its
leading multiple sclerosis therapies, and the company generates more
than $5 billion in annual revenues. For product labeling, press releases
and additional information about the company, please visit www.biogenidec.com.